A Randomized, Single Dose, Crossover Study in Healthy Volunteers to Investigate the Relative Bioavailability of Linaprazan for a New Oral Tablet Formulation of Linaprazan Glurate, and to Assess the Effect of Food on the Pharmacokinetics of Linaprazan
Latest Information Update: 08 Apr 2025
At a glance
- Drugs Linaprazan-glurate (Primary)
- Indications Oesophagitis
- Focus Pharmacokinetics
- Acronyms BA; C-0I-2022 C-0I-2022
- Sponsors Cinclus Pharma
Most Recent Events
- 17 Jan 2023 Status changed from recruiting to completed.
- 20 Dec 2022 Planned primary completion date changed from 2 Dec 2022 to 30 Dec 2022.
- 28 Nov 2022 New trial record